Impact of Age-Related Genetic Differences on the Therapeutic Outcome of Papillary Thyroid Cancer.

Kim, Seok-Mo; Kim, Soo Young; Park, Cheong Soo; Chang, Hang-Seok; Park, Ki Cheong

Kim, Seok-Mo; Kim, Soo Young; Park, Cheong Soo; Chang, Hang-Seok; Park, Ki Cheong.

Afiliação

Kim SM; Thyroid Cancer Center, Gangnam Severance Hospital, Department of Surgery, Yonsei University College of Medicine, Seoul 120-752, Korea.
Kim SY; Gangnam Severance Hospital, Department of Surgery, Yonsei University College of Medicine, 211, Eonjuro, Gangnam-gu, Seoul 135-720, Korea.
Park CS; Thyroid Cancer Center, Gangnam Severance Hospital, Department of Surgery, Yonsei University College of Medicine, Seoul 120-752, Korea.
Chang HS; Gangnam Severance Hospital, Department of Surgery, Yonsei University College of Medicine, 211, Eonjuro, Gangnam-gu, Seoul 135-720, Korea.
Park KC; Thyroid Cancer Center, Gangnam Severance Hospital, Department of Surgery, Yonsei University College of Medicine, Seoul 120-752, Korea.

Cancers (Basel) ; 12(2)2020 Feb 14.

Article em En | MEDLINE | ID: mdl-32075109

Palavras-chave

EMT; FGFR; Lenvatinib; Sorafenib; papillary thyroid carcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google